Skip to main content

Innovation
platform and hub

Tafelberg Ventures

We are building a Health Innovation and Venture Building Platform at FN Olomouc — the simplest route for innovators into clinical practice and health data, and from research to real-world impact.

And we want to build it with you.

Venture ≠ Venture capital

There is “Ventures” in our name. That does not make us an investment fund. It describes how we work.

Venture

A venture is, by nature, a risky business undertaking with an uncertain outcome.

Venture building

Venture building is a systematic process that tests a new business idea step by step, with small investments and clear go / pivot / stop decisions. Serious capital comes only once there is evidence.

How a project moves forward

  1. Small step

    Test the riskiest assumption first, with a small investment.

  2. Evidence

    Clinical, user or market data, not opinions.

  3. Decision

    Go
    continue to the next step
    Pivot
    change direction
    Stop
    end early and cheaply
  4. Capital

    Larger investment comes once the evidence is there.

Co-design phase · Open now

We are not building this for ourselves. We are building it for you

To create a system that truly fits the real needs of everyone who will work with it, we need to know as much as possible about you — your plans, your needs, and the obstacles you face. Your input will directly shape what we build first.

  • Clinicians & Researchers
  • Startups & Innovators
  • Investors
  • Industry & Corporates
  • Public Bodies & Others
  1. Tell us about you

    Who you are, what you are working on, and what you would need from a hospital-based innovation platform.

  2. We confirm and listen

    We confirm that we have received your input and work with it responsibly as we design the concept.

  3. We come back when it is ready

    We will get in touch once the service designed for you is actually ready.

Share your needs

Already have a concrete project? The questionnaire will lead you on to our pitch step.

From Clinic to Real-World Impact

We are building Tafelberg Ventures as the innovation and venture-building platform of FN Olomouc — bridging clinical excellence with entrepreneurial capital.

Our aim is to turn medical research, biomedical expertise, and hospital data into real-world health solutions that improve patients’ lives, and to support clinicians, researchers, and innovators in developing ideas with genuine patient impact — through spin-offs, commercial partnerships, and open innovation.

Clinical Depth

Rooted in real hospital practice and evidence-based research. Every innovation we support will have to show genuine clinical relevance and patient benefit.

Entrepreneurial Drive

We believe great research deserves to reach the world. We are building the business infrastructure, networks, and mentorship that turn ideas into ventures.

Evidence-based Impact

Results matter. We will measure success in patient outcomes, commercial traction, and the systemic change we help to enable in healthcare.

The Shortest Path from Idea to Clinic

Access to the clinical environment and to health data is the hardest step for every health innovation. That is exactly where we want to make the biggest difference.

TafelVent Gate

Flagship · in design

The simplest possible access to clinical data and practice.

One gateway for innovation partners to anonymised health and medical data and to the clinical environment of FN Olomouc — clear rules and predictable timelines instead of months spent looking for the right door.

  • Anonymised health and medical data within a clear legal framework
  • Pilot sites and clinical validation in real hospital practice
  • Clinical experts and key opinion leaders for your project
  • One entry point with transparent rules and predictable timelines

Our goal: to make FN Olomouc the easiest hospital in the Czech Republic to innovate with.

Two-way Needs Registry

In design

Start with what is genuinely needed.

Clinicians tell us which real problems they face every day. Innovators tell us what they need from a hospital to move forward. We match both sides — so that new solutions start from real clinical needs, not from what is easiest to build.

The Rules Are Changing in 2027

From 1 January 2027, the new Czech Act on Research, Development, Innovation and Knowledge Transfer (No. 328/2025 Coll.) makes it considerably easier for public research organisations — university hospitals included — to bring their results to market. We want FN Olomouc to be ready on day one.

Simpler licensing

State-funded organisations will be able to license their own research results without the consent of their founding ministry — a faster, more direct way to work with companies.

A legal basis for spin-offs

Institutional support may be used to set up knowledge-transfer companies, with profits returning to research. Turning clinical research into ventures gets a clear legal footing.

Transfer becomes a duty

Knowledge transfer becomes a statutory part of research, with yearly reporting of licences and transfer companies. It is no longer an optional extra — it needs a home.

What TAFELBERG Stands For

Tafelberg Ventures

The summit where all nine meet — one platform connecting clinical practice, research, capital, and industry. We are building it now, together with those it is meant to serve.

Technology

Driving innovation through cutting-edge MedTech solutions and digital health infrastructure built for real clinical environments.

Artificial Intelligence

Harnessing AI to transform healthcare data into actionable clinical and commercial insights that accelerate diagnosis, treatment, and research.

Future Health

Building the healthcare platform of tomorrow — proactive, personalized, predictive, and grounded in the realities of modern medicine.

Entrepreneurship

Empowering founders and innovators with hospital-grade validation, clinical access, and venture support to bring ideas to market.

Longevity

Advancing science and business at the frontier of healthy aging, precision medicine, and evidence-backed longevity interventions.

Biomedical

Grounded in world-class biomedical research and clinical expertise at one of the Czech Republic’s top teaching hospitals.

Evidence-based

Every innovation validated against rigorous clinical evidence and real-world outcomes — not just theory or prototype-stage assumptions.

Research

Deep integration with academic and applied research programs to accelerate translational medicine and bring discoveries to patients faster.

Growth

Scaling healthcare ventures from concept to commercialization with strategic capital connections, partnership networks, and venture-building expertise.

Beyond the acronym, Tafelberg Ventures is equally focused on Medicine, Prevention and Startups — integrating clinical practice, proactive health innovation, and entrepreneurial venture-building into one cohesive platform.

The Innovation Platform

This is the platform we are setting out to build: Tafelberg Ventures at the intersection of clinical excellence, capital flows, research infrastructure, and commercial partnerships — a healthcare innovation flywheel.

Platform services

TafelVentVenture Building

TafelVentInfrastructure
Labs / Testbeds

Platform players

FN OlomoucClinical Settings

MarketCompanies &
Commercial Partners

FN OlomoucData & ICT

PublicState / Public
Stakeholders

CapitalVenture / Private Capital

CapitalGrants & Public Funds

Platform
incubation

Portfolio project / venture

Portfolio project / venture

Portfolio project / venture

Portfolio project / venture

FN projects

Startups / SMEs

External projects

FN projects

Startups / SMEs

External projects

SUPPORT/SERVICES SUPPORT/SERVICES APPLICATION/SELECTION APPLICATION/SELECTION

Built for Every Innovator

Whether you come from the lab, the clinic, or the boardroom — we are designing the platform around what you need. This is what we plan to offer, and your input will decide what comes first.

Clinicians & Researchers

You have the knowledge.
We want to handle the rest

You should not have to become an entrepreneur. You need a partner who can translate your clinical insight into a scalable solution. We are building the structure, legal setup, business mentoring, and capital connections for this — so you can stay focused on what you do best.

  • Business development support
  • IP protection and spin-off guidance
  • A route to clinical validation at FN Olomouc
  • Connections to investors and industry partners

“My job is medicine, not business” — we hear that. And we agree.

Startups & Innovators

Validate in a real hospital.
Scale with confidence

Clinical validation is the hardest and most valuable step in MedTech. Through TafelVent Gate we want to open FN Olomouc for structured pilots, access to anonymised data within legal frameworks, and co-development with clinicians and researchers.

  • Structured clinical pilots
  • Access to anonymised data and cohorts
  • Co-development with clinical specialists
  • Guidance on regulatory and reimbursement pathways

“We have the product — we need clinical proof.”

Investors & Capital Partners

Deal flow from the heart
of clinical practice

Projects in our future pipeline will be assessed by clinicians, tested against real patient needs, and checked for commercial viability. We want to connect venture funds, family offices, and angel investors with innovations that have a real hospital behind them.

  • Clinically assessed deal flow
  • Co-investment alongside public grants
  • Early access to spin-off projects
  • Strategic partnership opportunities

“Where do I find validated MedTech opportunities in Central Europe?”

Industry & Corporate Partners

A direct route to clinical
co-development

We want to give Pharma, MedTech, Digital Health, and Life Sciences companies a structured gateway into FN Olomouc, one of the Czech Republic’s leading university hospitals — to pilot technologies, run studies, or co-develop solutions with clinical teams under clear rules.

  • Clear frameworks for industry collaboration
  • Access to clinical departments and data
  • Joint R&D and grant applications
  • Support for regional market entry

“We need a real hospital partner for our innovation pipeline.”

How the Pipeline Will Work

From a first idea to a scaled health innovation — the programmes we are designing, stage by stage. Their final shape will follow what you tell us.

  1. Idea & Discovery

    Identifying and evaluating innovations with genuine clinical potential — feasibility, patient relevance, and commercial fit, assessed together with your team.

    Open to all

  2. Clinical Validation

    Structured pilots within FN Olomouc departments. Real data, real clinical settings, real feedback. This is where ideas become evidence.

    Cohort-based

  3. Incubation & Build

    Company setup, IP structuring, product development, team building, and first capital. We want to provide the scaffolding — you build the company.

    Selected projects

  4. Scale & Commercialise

    Growth financing, market entry, regulatory approval, and international expansion — opening doors to investors, industry partners, and health markets.

    Portfolio ventures

Between every stage: a decision based on evidence
GoPivotStop

Building It Together

We are building the platform together with investors and innovators who share our goal — and we are looking for more.

A Question That Does Not Fit the Questionnaire?

The needs questionnaire is the best way to help shape the platform. For anything else — press, partnerships, or a simple question — write to us here.

We read every message.